'Why we do What we do in Cardiology'

Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib


Listen Later

Key points of the DANPACE II study on atrial pacing and atrial fibrillation in sinus node dysfunction:

1. Minimizing atrial pacing in pacemakers doesn't prevent atrial fibrillation (AF):

• 46% of patients regardless of pacing rate (40bpm or 60bpm) experienced an AF episode lasting over 6 minutes during 2 years.

• No difference in AF rates across age, heart rhythm patterns, or prior AF history.

2. Safety concerns: Lower pacing rate linked to increased presyncope/syncope (22% vs 13%).

• Some patients initially assigned to 40bpm required device reprogramming to a higher rate due to these issues.

3. Standard pacing settings (60bpm with rate-adaptive pacing) are recommended unless individual needs require adjustment.

• Rate-adaptive pacing adjusts to activity level, providing adequate heart rate while minimizing unnecessary atrial pacing.

4. Optimal pacing rate remains under investigation for further minimizing AF and syncope.

• Future studies are needed to identify specific patient groups who might benefit from atrial pacing minimization.

5. Overall, DANPACE II clarifies pacemaker programming strategies for sinus node dysfunction patients.

• While minimizing atrial pacing isn't generally effective for preventing AF, the study provides valuable insights for optimizing pacemaker settings to ensure patient safety and well-being.


Link to article:

https://doi.org/10.1093/eurheartj/ehad564

...more
View all episodesView all episodes
Download on the App Store

'Why we do What we do in Cardiology'By Bishnu Subedi


More shows like 'Why we do What we do in Cardiology'

View all
This Week in Cardiology by Medscape

This Week in Cardiology

906 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,150 Listeners